T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$2.11B |
| 2 |
Linde
LIN
|
+$1.34B |
| 3 |
American International
AIG
|
+$1.34B |
| 4 |
Marvell Technology
MRVL
|
+$1.28B |
| 5 |
TSS
Total System Services, Inc.
TSS
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$2.27B |
| 2 |
Eli Lilly
LLY
|
+$1.64B |
| 3 |
NVIDIA
NVDA
|
+$1.59B |
| 4 |
RHT
Red Hat Inc
RHT
|
+$1.55B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.88% |
| 2 | Healthcare | 16.96% |
| 3 | Financials | 13.79% |
| 4 | Consumer Discretionary | 13.57% |
| 5 | Industrials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
RingCentral
RNG
$5.25B
| $2.71M | ﹤0.01% |
23,565
+36
| +0.2% | +$4.15K |
|
1502
HEICO Corp
HEI
$52.1B
| $2.67M | ﹤0.01% |
19,940
-896
| -4% | -$99.7K |
|
1503
Shenandoah Telecom
SHEN
$721M
| $2.66M | ﹤0.01% |
69,170
+3,639
| +6% | +$151K |
|
1504
Rithm Capital
RITM
$5.71B
| $2.66M | ﹤0.01% |
172,926
+239
| +0.1% | +$3.9K |
|
|
WBC
1505
DELISTED
WABCO HOLDINGS INC.
WBC
| $2.66M | ﹤0.01% |
20,041
-337,689
| -94% | -$44.5M |
|
1506
Herbalife
HLF
$1.23B
| $2.65M | ﹤0.01% |
62,084
-905
| -1% | -$42.9K |
|
1507
MasTec
MTZ
$22.6B
| $2.64M | ﹤0.01% |
51,268
+132
| +0.3% | +$6.52K |
|
1508
AptarGroup
ATR
$8.43B
| $2.6M | ﹤0.01% |
20,937
+27
| +0.1% | +$3.08K |
|
1509
Allegiant Air
ALGT
$2.36B
| $2.59M | ﹤0.01% |
18,044
-109
| -0.6% | -$15.3K |
|
1510
Chemours
CC
$2.29B
| $2.59M | ﹤0.01% |
107,886
+87
| +0.1% | +$2.56K |
|
|
MDR
1511
DELISTED
McDermott International
MDR
| $2.58M | ﹤0.01% |
267,556
+31,780
| +13% | +$254K |
|
1512
Jabil
JBL
$38.8B
| $2.58M | ﹤0.01% |
81,769
+167
| +0.2% | +$4.79K |
|
1513
Idacorp
IDA
$8.21B
| $2.58M | ﹤0.01% |
25,692
-3,251
| -11% | -$328K |
|
|
YELL
1514
DELISTED
Yellow Corporation Common Stock
YELL
| $2.58M | ﹤0.01% |
640,045
+43,600
| +7% | +$252K |
|
1515
Aecom
ACM
$7.86B
| $2.57M | ﹤0.01% |
67,925
+44
| +0.1% | +$1.46K |
|
1516
Credit Acceptance
CACC
$6.05B
| $2.57M | ﹤0.01% |
5,314
-4
| -0.1% | -$1.9K |
|
1517
Cullen/Frost Bankers
CFR
$10.4B
| $2.54M | ﹤0.01% |
27,125
+1,504
| +6% | +$147K |
|
1518
NETSCOUT
NTCT
$2.87B
| $2.53M | ﹤0.01% |
99,520
-215,655
| -68% | -$5.79M |
|
1519
Sabra Healthcare REIT
SBRA
$5.15B
| $2.52M | ﹤0.01% |
128,132
+1,256
| +1% | +$24.5K |
|
1520
HNI Corp
HNI
$3.55B
| $2.52M | ﹤0.01% |
71,237
+100
| +0.1% | +$3.59K |
|
1521
American States Water
AWR
$3.49B
| $2.52M | ﹤0.01% |
33,479
+477
| +1% | +$34.4K |
|
1522
SolarEdge
SEDG
$1.98B
| $2.5M | ﹤0.01% |
40,100
| – | – |
|
|
SRG
1523
Seritage Growth Properties
SRG
$131M
| $2.5M | ﹤0.01% |
58,316
+85
| +0.1% | +$3.74K |
|
1524
First Horizon
FHN
$12.3B
| $2.5M | ﹤0.01% |
167,207
-10,875
| -6% | -$157K |
|
1525
Pricesmart
PSMT
$5.49B
| $2.49M | ﹤0.01% |
48,684
-395,132
| -89% | -$22M |
|
Similar funds
T. Rowe Price Associates's Q2 2019 Portfolio in Review
As of Q2 2019, T. Rowe Price Associates held 2,600 positions worth $712B, up 4.7% from $680B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
T. Rowe Price Associates's Q2 2019 filing shows 72 new, 1,394 increased, 949 reduced and 59 closed positions. Its largest new stake was Alcon: 36,020,796 shares worth $2.23B. The largest sale was UnitedHealth, an estimated $2.27B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2019 buy was Alcon: 36,020,796 shares worth $2.23B.
- T. Rowe Price Associates added most to Linde in Q2 2019, an estimated $1.34B increase.
- T. Rowe Price Associates's biggest Q2 2019 reduction was UnitedHealth, cutting an estimated $2.27B.
- T. Rowe Price Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $609M.
- T. Rowe Price Associates's ten largest holdings make up 21% of its $712B portfolio in Q2 2019.
- T. Rowe Price Associates opened 72 new positions and closed 59 in Q2 2019.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $712B.
Based on T. Rowe Price Associates's 13F filing for Q2 2019, filed 15 Aug 2019.